Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Davis Todd C

Over the trailing 90 days, Davis Todd C (Director at Pelthos Therapeutics Inc.) bought $1.0M of stock across 3 companies, per 4 SEC Form 4 transactions.

Role: Director
Companies: PTHS LGND PVLA
Window: Trailing 90 days · 4 transactions · CIK 1392029
Net activity: +$1.0M ($1.0M bought · $0 sold)
Source: Official filings on sec.gov ↗

By Company (Trailing 90 Days)

Symbol	Company	Txns	Bought	Sold	Net
PTHS	Pelthos Therapeutics Inc.	2	$1,000K	—	$1,000K
LGND	LIGAND PHARMACEUTICALS INC	1	$21K	—	$21K
PVLA	PALVELLA THERAPEUTICS, INC.	1	—	—	$0

Transactions (4)

Date	Symbol	Type	Shares	Value	Description
2026-06-30	LGND	Buy	132	$21K	Other acquisition or disposition
2026-06-11	PTHS	Buy	503	$14K	Open market or private purchase
2026-06-11	PTHS	Buy	35.4K	$986K	Open market or private purchase
2026-06-10	PVLA	Buy	3.0K	$0	Grant, award or other acquisition

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Davis's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free